Bridgewater, NJ – According to filings with the U.S. Securities and Exchange Commission, Solaris Pharma is raising $10,000,000.00 in new funding. Sources indicate as part of senior management President, Srinivasan Raghavan played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Solaris Pharma

Solaris Pharma Corporation was founded in 2014 with the vision of improving the patients’ quality of life through development of niche pharmaceutical products. Located in Bridgewater, New Jersey, Solaris Pharma Corporation has a fully equipped Research & Development facility with expertise in the development of generic and specialty products.

To learn more about Solaris Pharma, visit http://www.solaris-pharma.com/

Contact:
Srinivasan Raghavan, President
908-864-0404

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved